INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Delivering Innovative Solutions & Relied Upon Turn-Key Systems
Explore advanced aseptic fill-finish automation, modular isolation systems, and the technical drivers behind out-of-nest processing for ready-to-use containers.
-
Enhancing Biological Indicators With Enzyme Indicators
Achieve greater process assurance in decontamination cycles. Combining traditional indicators with rapid, quantitative enzyme data reveals performance trends to optimize validation.
-
Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing
This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.
-
Stability Issues Unique To Liquid Injectables And How To Avoid Them
Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.
-
Accountability For The Whole PFS System5/21/2026
When component suppliers only own their part, system-level performance becomes your responsibility. And if something fails, accountability disappears into the gaps.
-
5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes5/23/2025
In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
Flying On Two Wings: Balancing Local Agility And Global Quality In China8/12/2026
As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.
-
Future-Proofing Aseptic Manufacturing3/27/2025
Investing in adaptable aseptic manufacturing pays off. Find out how flexible systems, despite higher initial costs, handle complex drugs and changing volumes to boost productivity and quality.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Oral non-sterile liquid manufacturing options offer a variety of liquid and suspension dosage solutions designed specifically around palatability — progressing from formulation development through full-scale commercial production.
-
Our Bench Vision Unit has been developed to provide maximum flexibility, with the same software and component design as our automatic visual inspection equipment used on production lines throughout the world.
- Container range: ampoules, vials, cartridges, syringes
- Inspected products: water-like, viscous, suspensions
-
Safer hazardous compounding starts with contained airflow, dependable asepsis, and operator-first ergonomics. See how compact design, glove testing, and remote support come together to improve control.
-
The pharmaceutical industry has steadily moved to increased production and handling of sterile highly potent active ingredients (HPAPIs). Dec’s containment technologies comply with pharmaceutical quality manufacturing standards and are available for aseptic operations.
-
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.